MUC16 and ovarian carcinoma: Redman et al. detected the CA125 value before the third chemotherapy in 78 patients with stage II~IV ovarian cancer after the completion of two courses of chemotherapy, and the analysis showed that those with CA125 ≤ 35U/mL had a 1-year survival rate of 96%, while those with CA125>35U/mL had a 1-year survival rate of 15% 14.